Pathstone Family Office, LLC Meridian Bioscience Inc Transaction History

Pathstone Family Office, LLC

  • $15.6 Billion
  • Q3 2023

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Oct 23, 2023
SELL
$31.15 - $33.39 $10,746 - $11,519
-345 Reduced 1.75%
19,329 $641,000
Q4 2022

Feb 13, 2023
SELL
$31.15 - $33.39 $10,746 - $11,519
-345 Reduced 1.75%
19,329 $641,000
Q3 2022

Oct 23, 2023
BUY
$30.9 - $33.55 $32,970 - $35,797
1,067 Added 5.73%
19,674 $620,000
Q3 2022

Nov 14, 2022
BUY
$30.9 - $33.55 $32,970 - $35,797
1,067 Added 5.73%
19,674 $620,000
Q2 2022

Oct 23, 2023
BUY
$23.75 - $31.69 $441,916 - $589,655
18,607 New
18,607 $566,000
Q2 2022

Aug 15, 2022
BUY
$23.75 - $31.69 $441,916 - $589,655
18,607 New
18,607 $566,000

Others Institutions Holding VIVO

# of Institutions
10
Shares Held
113K
Call Options Held
0
Put Options Held
0
View Full List

About MERIDIAN BIOSCIENCE INC

VIVO Quotes by TradingView
  • Ticker VIVO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 43,748,000
  • Description
  • Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...
More about VIVO
Track This Portfolio

Track Pathstone Family Office, LLC Portfolio

Follow Pathstone Family Office, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pathstone Family Office, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pathstone Family Office, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email